Research Article
Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study
| Characteristics | Case group () | Control group () | value |
| Age, years | 27 17–39] | 28 17–40] | 0.71 | Parity, | 1 0–4] | 1 0–4] | 0.87 | Ethnicity | | | | Caucasian | 5 (8%) | 22 (34%) | 0.00 | African descent | 38 (59%) | 15 (23%) | Other | 11 (17%) | 16 (25%) | Unknown | 10 (16%) | 11 (17%) | Education level | | | | Lower education | 13 (20%) | 10 (16%) | 0.18 | Middle education | 21 (33%) | 12 (19%) | Higher education | 7 (11%) | 12 (19%) | Unknown | 23 (36%) | 29 (46%) | Comorbidities† | | | | Overall | 13 (20%) | 12 (19%) | 0.12 | Preexisting hypertension | 1 (2%) | 2 (3%) | Preexisting diabetes | 1 (2%) | 2 (3%) | Renal/liver transplant | 1 (2%) | 0 | Renal malignancy in the past | 1 (2%) | 1 (2%) | Irritable bowel syndrome | 0 | 1 (2%) | Uterus myomatosus | 2 (3%) | 1 (2%) | Primary hyperoxaluria type 1 | 1 (2%) | 0 | Asthma | 1 (2%) | 1 (2%) | Hypothyroidism | 2 (3%) | 1 (2%) | Sickle cell anemia | 2 (3%) | 1 (2%) | Rheumatoid arthritis | 1 (2%) | 0 | Ehlers-Danlos type III | 0 | 1 (2%) | Alpha thalassemia | 0 | 1 (2%) | HIV infection | 1 (2%) | 1 (2%) | IL-12 receptor deficiency | 0 | 1 (2%) | Unknown | 4 | 0 | Familial diseases | | | | None | 14 (22%) | 36 (56%) | 0.00 | Hypertension | 14 (22%) | 8 (13%) | Diabetes | 6 (9%) | 3 (5%) | Hypertension and diabetes | 18 (28%) | 13 (20%) | Unknown | 12 (19%) | 4 (6%) | Number of fetuses | | | | Singleton pregnancy | 59 (92%) | 59 (92%) | 1.00 | Twin pregnancy | 5 (8%) | 5 (8%) |
|
|
Data shown as median [range] or (%); †patients could have more than one comorbidity.
|